Rachel Gurrell

733 total citations · 1 hit paper
23 papers, 485 citations indexed

About

Rachel Gurrell is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Rachel Gurrell has authored 23 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Rachel Gurrell's work include Neuroscience and Neuropharmacology Research (8 papers), Pain Mechanisms and Treatments (5 papers) and Epilepsy research and treatment (5 papers). Rachel Gurrell is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Pain Mechanisms and Treatments (5 papers) and Epilepsy research and treatment (5 papers). Rachel Gurrell collaborates with scholars based in United Kingdom, United States and Australia. Rachel Gurrell's co-authors include Vivek Dua, Peter T. Loudon, Caroline Benn, Ciara Vangjeli, Andrew Pike, Richard Storer, Richard P. Butt, R.L. Fish, Mark Whitlock and Zheng He and has published in prestigious journals such as PLoS ONE, Neurology and Pain.

In The Last Decade

Rachel Gurrell

22 papers receiving 457 citations

Hit Papers

Physiology of Hyperuricemia and Urate-Lowering Treatments 2018 2026 2020 2023 2018 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Gurrell United Kingdom 13 183 161 131 73 62 23 485
Pınar Akan Türkiye 14 41 0.2× 89 0.6× 84 0.6× 74 1.0× 16 0.3× 37 501
Brandi M. Wynne United States 14 37 0.2× 229 1.4× 47 0.4× 69 0.9× 14 0.2× 28 535
Z. S. Ercan Türkiye 14 40 0.2× 170 1.1× 106 0.8× 17 0.2× 66 1.1× 82 691
Anna Tankiewicz‐Kwedlo Poland 16 87 0.5× 240 1.5× 17 0.1× 184 2.5× 45 0.7× 43 799
Michael S. Yates United Kingdom 14 61 0.3× 139 0.9× 46 0.4× 49 0.7× 34 0.5× 26 462
Haibo Wu China 13 36 0.2× 80 0.5× 49 0.4× 29 0.4× 18 0.3× 43 437
Hye-Yeon Cho South Korea 13 23 0.1× 143 0.9× 101 0.8× 35 0.5× 43 0.7× 41 512
Ayhan Çetinkaya Türkiye 12 19 0.1× 86 0.5× 46 0.4× 58 0.8× 36 0.6× 51 361
L Martis Poland 12 147 0.8× 67 0.4× 76 0.6× 26 0.4× 6 0.1× 32 451

Countries citing papers authored by Rachel Gurrell

Since Specialization
Citations

This map shows the geographic impact of Rachel Gurrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Gurrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Gurrell more than expected).

Fields of papers citing papers by Rachel Gurrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Gurrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Gurrell. The network helps show where Rachel Gurrell may publish in the future.

Co-authorship network of co-authors of Rachel Gurrell

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Gurrell. A scholar is included among the top collaborators of Rachel Gurrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Gurrell. Rachel Gurrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurrell, Rachel, Ih Chang, Gabriël E. Jacobs, et al.. (2023). Phase 1 Trial of Darigabat for the Reduction of Acute Psychological and Physiological Panic and Fear Symptoms Following CO2 Inhalation in Healthy Participants (S8.005). Neurology. 100(17_supplement_2). 1 indexed citations
2.
Whitmore, Laura M., et al.. (2022). Ensuring the Continuity of Data Collection in a Focal Epilepsy Clinical Trial During the COVID-19 Pandemic (P2-8.007). Neurology. 98(18_supplement). 1 indexed citations
3.
Gurrell, Rachel, et al.. (2022). Pronounced antiseizure activity of the subtype‐selective GABAA positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy. CNS Neuroscience & Therapeutics. 28(11). 1875–1882. 13 indexed citations
4.
French, Jacqueline A., Dennis Dlugos, Gail Farfel, et al.. (2022). Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years. Epilepsia. 63(10). 2664–2670. 7 indexed citations
5.
Gurrell, Rachel, Mark Whitlock, Hua Wei, Zhongzhou Shen, & Adam Ogden. (2021). Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABAA‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers. Clinical Pharmacology in Drug Development. 10(7). 756–764. 6 indexed citations
6.
Amerongen, Guido van, Pieter Siebenga, Rachel Gurrell, et al.. (2019). Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans. British Journal of Anaesthesia. 123(2). e194–e203. 20 indexed citations
7.
Gurrell, Rachel, Donal Gorman, Mark Whitlock, et al.. (2019). Photosensitive epilepsy. Neurology. 92(15). 30 indexed citations
9.
Gurrell, Rachel, Sridhar Duvvuri, Pengling Sun, & Nicholas DeMartinis. (2018). A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson’s Disease. Clinical Drug Investigation. 38(6). 509–517. 14 indexed citations
10.
Duveau, Venceslas, et al.. (2018). Pronounced antiepileptic activity of the subtype‐selective GABAA‐positive allosteric modulator PF‐06372865 in the GAERS absence epilepsy model. CNS Neuroscience & Therapeutics. 25(2). 255–260. 23 indexed citations
11.
Benn, Caroline, Vivek Dua, Rachel Gurrell, et al.. (2018). Physiology of Hyperuricemia and Urate-Lowering Treatments. Frontiers in Medicine. 5. 160–160. 222 indexed citations breakdown →
12.
Hui, Flora, Christine T. O. Nguyen, Zheng He, et al.. (2017). Retinal and Cortical Blood Flow Dynamics Following Systemic Blood-Neural Barrier Disruption. Frontiers in Neuroscience. 11. 568–568. 15 indexed citations
13.
Charng, Jason, Zheng He, Algis J. Vingrys, et al.. (2016). Retinal Electrophysiology Is a Viable Preclinical Biomarker for Drug Penetrance into the Central Nervous System. Journal of Ophthalmology. 2016. 1–12. 5 indexed citations
14.
Dua, Vivek, et al.. (2016). Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649. Clinical Rheumatology. 35(8). 2045–2051. 16 indexed citations
15.
Charng, Jason, Zheng He, Bang V. Bui, et al.. (2016). Implantation and Recording of Wireless Electroretinogram and Visual Evoked Potential in Conscious Rats. Journal of Visualized Experiments. 1 indexed citations
16.
Amerongen, Guido van, Marieke L. de Kam, Jasper Stevens, et al.. (2016). The use of a battery of pain models to detect analgesic properties of compounds: a two‐part four‐way crossover study. British Journal of Clinical Pharmacology. 83(5). 976–990. 27 indexed citations
17.
Richardson, Denise, et al.. (2015). Tibial Nerve Transection (TNT) Model of Neuropathic Pain in the Rat. Figshare. 1 indexed citations
18.
Hui, Flora, Christine T. O. Nguyen, Phillip Bedggood, et al.. (2014). Quantitative Spatial and Temporal Analysis of Fluorescein Angiography Dynamics in the Eye. PLoS ONE. 9(11). e111330–e111330. 16 indexed citations
19.
Charng, Jason, Christine T. O. Nguyen, Zheng He, et al.. (2013). Conscious Wireless Electroretinogram and Visual Evoked Potentials in Rats. PLoS ONE. 8(9). e74172–e74172. 17 indexed citations
20.
Ploeger, Bart A., et al.. (2011). A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered rat. Journal of Pharmacokinetics and Pharmacodynamics. 38(6). 697–711. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026